Your browser doesn't support javascript.
loading
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial.
Sabatier, Renaud; Rousseau, Frédérique; Joly, Florence; Cropet, Claire; Montégut, Coline; Frindte, Johanna; Cinieri, Saverio; Guerra Alía, Eva M; Polterauer, Stephan; Yoshida, Hiroyuki; Vergote, Ignace; Colombo, Nicoletta; Hietanen, Sakari; Largillier, Rémi; Canzler, Ulrich; Gratet, Alain; Marmé, Frederik; Favier, Laure; Pujade-Lauraine, Eric; Ray-Coquard, Isabelle.
Afiliação
  • Sabatier R; Department of Medical Oncology, Institut Paoli-Calmettes, CRCM, Aix-Marseille Univ, Inserm, CNRS, Marseille, and GINECO, France. Electronic address: sabatierr@ipc.unicancer.fr.
  • Rousseau F; Department of Medical Oncology, Institut Paoli-Calmettes, CRCM, Aix-Marseille Univ, Inserm, CNRS, Marseille, and GINECO, France.
  • Joly F; Centre François Baclesse, Caen, and GINECO, France.
  • Cropet C; Centre Léon Bérard, Lyon, France.
  • Montégut C; Department of Medical Oncology, Institut Paoli-Calmettes, CRCM, Aix-Marseille Univ, Inserm, CNRS, Marseille, and GINECO, France.
  • Frindte J; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, and AGO, Germany.
  • Cinieri S; UOC Oncologia Medica - Ospedale Senatore Antonio Perrino, Brindisi, and MITO, Italy.
  • Guerra Alía EM; Hospital Ramón y Cajal, Madrid, and GEICO, Spain.
  • Polterauer S; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, and AGO-Austria, Austria.
  • Yoshida H; Saitama Medical University, Saitama, and GOTIC, Japan.
  • Vergote I; University Hospital Leuven, Leuven Cancer Institute, Leuven, and BGOG, European Union, Belgium.
  • Colombo N; University of Milan-Bicocca and Istituto Europeo di Oncologia, Milan, and MANGO, Italy.
  • Hietanen S; Turku University Hospital, Turku, and NSGO, Finland.
  • Largillier R; Centre Azuréen de Cancérologie, Mougins, and GINECO, France.
  • Canzler U; Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, and AGO, Germany.
  • Gratet A; Clinique Pasteur, Toulouse, and GINECO, France.
  • Marmé F; Medical Faculty Mannheim, Heidelberg University, Mannheim, and AGO, Germany.
  • Favier L; Centre Georges François Leclerc, Dijon, and GINECO, France.
  • Pujade-Lauraine E; ARCAGY Research, Paris, and GINECO, France.
  • Ray-Coquard I; Centre Léon Bérard and University Claude Bernard Lyon 1, Lyon and GINECO, France.
Eur J Cancer ; 181: 42-52, 2023 03.
Article em En | MEDLINE | ID: mdl-36634389
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article